The Need to Study Tissue Biomarkers

News
Article

David L. Rimm MD, PhD, from Yale School of Medicine, discusses the need for further research into tissue biomarkers in breast cancer.

Clinical Pearls

David L. Rimm MD, PhD, Professor of Pathology and of Medicine (Medical Oncology), Director of Pathology Tissue Services, Director of Translational Pathology, Yale School of Medicine, discusses the need for further research into tissue biomarkers in breast cancer.

  • Tissue biomarkers may help to determine which patients will respond to certain drugs.
  • Biologically, cancers are different. It is important to be able to determine how patients will respond to treatment.

<<<

Go back to the SABCS conference page

Related Videos
Video 5 - "Second-Line Treatment Considerations and Improving Outcomes in Breast Cancer"
Video 4 - "Impressions on Safety Data from EMERALD Subgroup Analysis"
Related Content